Use of eculizumab in atypical uremic hemolytic syndrome in childhood: case report (original) (raw)

Abstract

To report a case of a patient who presented recurrence of aHUS after discontinuing use of Eculizumab.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (14)

  1. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J. 2009;361:1676-1687.
  2. Loirat C, Fremeaux-Bacchi V. Atypical hemolytic uremic syndrome. Orphanet J Rare Dis. 2011;6:60.
  3. Fakhouri F, Fremeaux-bacchi V. Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura? Nat Clin Pract Nephrol. 2007;3:679-687.
  4. Kavanagh D, Goodship H, Richards A. Atypical hemolytic uremic syndrome. Semin Nephrol. 2013;33:508-530.
  5. Nester C, Barbour T, de Cordoba S et al. Atypical aHUS: State of the art. Mol Immunol. 2015;67:31-42.
  6. Banerjee S. Hemolytic Uremic Syndrome. Indian Pediatr. 2009;46:1075- 1084.
  7. Taylor M, Neild G. Acute renal failure associated with microangiopathy (haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura). In: Davison A et al., editors. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press. 2005. p. 1545-1564.
  8. Loirat C, Saland J, Bitzan M. Management of hemolytic uremic syndrome. Presse Med. 2012;41:e115-e135.
  9. Tsai HM. Autoimmune thrombotic microangiopathy: advances in pathogenesis, diagnosis, and management. Semin Thromb Hemost. 2012;38(5):469-482.
  10. Zuber J, Fakhouri F, Roumenina LT et al. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol. 2012; 8:643-657.
  11. Ariceta G. Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS) -a question to be addressed in a scientific way. Pediatr Nephrol. 2019;34:943-949.
  12. Ariceta G, Besbas N, Johnson S et al. Guidelines for the investigation and initial therapy of diarrhea negative haemolytic uraemic syndrome. Pediatr Nephrol. 2009;24(4):687-696.
  13. Taylo S, Wigmore J, Goodship H. Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom. Br J Haematol. 2010;148(1):37-47.
  14. Kim SH Kim HY, Kim SY. Atypical Hemolytic uremic syndrome and eculizumab therapy in children. Korean J Pediatr. 2018;61(2):37-42.